UW researchers found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of ...

Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer baseAdvance SeaStar Medical’s ...

The CDC on Monday dramatically reduced the number of vaccines it recommends for all children. Here’s what parents should know ...

Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for SBS and MVID. In October 2025, as announced, the company ...

Company Expands Therapeutic Robotics Comprehensive Product Lineup Addressing Diverse Emotional and Clinical Support NeedsLAS ...

The campuses could become homes for alternative schools, administrative departments and outside “community partners,” the ...

Among adolescents with asthma and overweight or obesity, the relative risk for acute asthma exacerbations was significantly reduced with GLP-1 receptor agonist use vs. nonpharmacological weight ...

Bonneville, Chickasaw, Eccleston, McCoy, Meadow Woods, and Orlo Vista elementary schools, and Union Park Middle School in ...

“Today marks a decisive change in federal nutrition policy,” the health secretary, Robert F. Kennedy Jr., said at a briefing ...

Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...

DNLI maps 2026 goals as it awaits FDA action on tividenofusp alfa, targeting first commercial validation amid multiple late-stage readouts.

The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...